← Alle mensen

FM

Federica Miglietta

4 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Tumor-Infiltrating Lymphocytes and Survival Outcomes in Early ERBB2-Positive Breast Cancer: 10-Year Analysis of the S...

JAMA oncology · 1 april 2025

Negen weken versus één jaar trastuzumab bij HER2-positief mammacarcinoom: meta-analyse

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 10 november 2023

Trastuzumab-lapatinib neoadjuvant bij HER2-positief mammacarcinoom: overlevingsanalyse

European journal of cancer (Oxford, England : 1990) · 2021-08

Multivariabele prognostische score bij HER2-positief vroeg mammacarcinoom

The Lancet. Oncology · 2020-11